Limits...
Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Survey of Canadian Gastroenterologists and Hepatologists.

Fortinsky KJ, Martel M, Razik R, Spiegle G, Gallinger ZR, Grover SC, Pavenski K, Weizman AV, Kwapisz L, Mehta S, Gray S, Barkun AN - Can J Gastroenterol Hepatol (2016)

Bottom Line: Patients with coronary artery disease (mean Hgb of 84.0 g/L versus 71.0 g/L; p < 0.01) or cirrhosis (mean Hgb of 74.4 g/L versus 71.0 g/L; p < 0.01) were transfused more liberally than healthy patients.Fewer than 15% would prescribe iron to patients with UGIB who are anemic upon discharge.Conclusions.

View Article: PubMed Central - PubMed

Affiliation: Division of Gastroenterology, University of Toronto, Toronto, ON, Canada.

ABSTRACT
Introduction. There is limited data evaluating physician transfusion practices in patients with acute upper gastrointestinal bleeding (UGIB). Methods. A web-based survey was sent to 500 gastroenterologists and hepatologists across Canada. The survey included clinical vignettes where physicians were asked to choose transfusion thresholds. Results. The response rate was 41% (N = 203). The reported hemoglobin (Hgb) transfusion trigger differed by up to 50 g/L. Transfusions were more liberal in hemodynamically unstable patients compared to stable patients (mean Hgb of 86.7 g/L versus 71.0 g/L; p < 0.001). Many clinicians (24%) reported transfusing a hemodynamically unstable patient at a Hgb threshold of 100 g/L and the majority (57%) are transfusing two units of RBCs as initial management. Patients with coronary artery disease (mean Hgb of 84.0 g/L versus 71.0 g/L; p < 0.01) or cirrhosis (mean Hgb of 74.4 g/L versus 71.0 g/L; p < 0.01) were transfused more liberally than healthy patients. Fewer than 15% would prescribe iron to patients with UGIB who are anemic upon discharge. Conclusions. The transfusion practices of gastroenterologists in the management of UGIB vary widely and more high-quality evidence is needed to help assess the efficacy and safety of selected transfusion thresholds in varying patients presenting with UGIB.

No MeSH data available.


Related in: MedlinePlus

The percentage of clinicians who prescribe iron therapy to anemic patients after upper gastrointestinal bleeding.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4940523&req=5

fig5: The percentage of clinicians who prescribe iron therapy to anemic patients after upper gastrointestinal bleeding.

Mentions: Few gastroenterologists (14.5%, 9.9%; 20.6%) stated they routinely prescribe iron to patients with UGIB who are anemic at discharge (Figure 5). Most of these clinicians reported prescribing oral iron (81.3% (74.7%; 86.5%)) while very few are prescribing intravenous iron (5.4% (2.9; 10.0%)).


Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Survey of Canadian Gastroenterologists and Hepatologists.

Fortinsky KJ, Martel M, Razik R, Spiegle G, Gallinger ZR, Grover SC, Pavenski K, Weizman AV, Kwapisz L, Mehta S, Gray S, Barkun AN - Can J Gastroenterol Hepatol (2016)

The percentage of clinicians who prescribe iron therapy to anemic patients after upper gastrointestinal bleeding.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4940523&req=5

fig5: The percentage of clinicians who prescribe iron therapy to anemic patients after upper gastrointestinal bleeding.
Mentions: Few gastroenterologists (14.5%, 9.9%; 20.6%) stated they routinely prescribe iron to patients with UGIB who are anemic at discharge (Figure 5). Most of these clinicians reported prescribing oral iron (81.3% (74.7%; 86.5%)) while very few are prescribing intravenous iron (5.4% (2.9; 10.0%)).

Bottom Line: Patients with coronary artery disease (mean Hgb of 84.0 g/L versus 71.0 g/L; p < 0.01) or cirrhosis (mean Hgb of 74.4 g/L versus 71.0 g/L; p < 0.01) were transfused more liberally than healthy patients.Fewer than 15% would prescribe iron to patients with UGIB who are anemic upon discharge.Conclusions.

View Article: PubMed Central - PubMed

Affiliation: Division of Gastroenterology, University of Toronto, Toronto, ON, Canada.

ABSTRACT
Introduction. There is limited data evaluating physician transfusion practices in patients with acute upper gastrointestinal bleeding (UGIB). Methods. A web-based survey was sent to 500 gastroenterologists and hepatologists across Canada. The survey included clinical vignettes where physicians were asked to choose transfusion thresholds. Results. The response rate was 41% (N = 203). The reported hemoglobin (Hgb) transfusion trigger differed by up to 50 g/L. Transfusions were more liberal in hemodynamically unstable patients compared to stable patients (mean Hgb of 86.7 g/L versus 71.0 g/L; p < 0.001). Many clinicians (24%) reported transfusing a hemodynamically unstable patient at a Hgb threshold of 100 g/L and the majority (57%) are transfusing two units of RBCs as initial management. Patients with coronary artery disease (mean Hgb of 84.0 g/L versus 71.0 g/L; p < 0.01) or cirrhosis (mean Hgb of 74.4 g/L versus 71.0 g/L; p < 0.01) were transfused more liberally than healthy patients. Fewer than 15% would prescribe iron to patients with UGIB who are anemic upon discharge. Conclusions. The transfusion practices of gastroenterologists in the management of UGIB vary widely and more high-quality evidence is needed to help assess the efficacy and safety of selected transfusion thresholds in varying patients presenting with UGIB.

No MeSH data available.


Related in: MedlinePlus